- Report
- May 2023
- 450 Pages
Global
From €3578EUR$4,000USD£3,146GBP
€4473EUR$5,000USD£3,933GBP
- Report
- February 2021
- 50 Pages
Global
From €2326EUR$2,600USD£2,045GBP
€2907EUR$3,250USD£2,556GBP
- Report
- March 2024
- 200 Pages
Global
From €3713EUR$4,150USD£3,264GBP
- Report
- March 2024
- 200 Pages
Global
From €3713EUR$4,150USD£3,264GBP
- Report
- January 2024
- 200 Pages
Global
From €3713EUR$4,150USD£3,264GBP
- Report
- January 2024
- 200 Pages
Global
From €3713EUR$4,150USD£3,264GBP
- Report
- July 2024
- 100 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Report
- July 2024
- 100 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Report
- July 2024
- 150 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Report
- July 2024
- 100 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Report
- June 2024
- 200 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Report
- June 2024
- 200 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Report
- June 2024
- 200 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Report
- April 2024
- 143 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €895EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Report
- March 2024
- 174 Pages
Global
From €5368EUR$6,000USD£4,719GBP
€6710EUR$7,500USD£5,899GBP
- Report
- February 2024
- 200 Pages
Global
From €5368EUR$6,000USD£4,719GBP
€6710EUR$7,500USD£5,899GBP
- Report
- November 2023
- 30 Pages
Global
From €2326EUR$2,600USD£2,045GBP
€2907EUR$3,250USD£2,556GBP
- Report
- April 2023
- 500 Pages
Global
From €2326EUR$2,600USD£2,045GBP
€2907EUR$3,250USD£2,556GBP
- Report
- April 2023
- 200 Pages
Global
From €2827EUR$3,160USD£2,485GBP
€3534EUR$3,950USD£3,107GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more